Cleared Traditional

K240664 - ALARA BMA Neuro Access Kit (ALARA BMAN and ALARA BMAC Kit)

K240664 is an FDA 510(k) clearance for ALARA BMA Neuro Access Kit (ALARA BMAN ..., manufactured by SurGenTec, LLC. The device is a Class 2 General & Plastic Surgery device with product code KNW cleared through the Traditional 510(k) pathway after a 154-day FDA review.

K240664 · SurGenTec, LLC · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2024
Decision
154d
Days
Class 2
Risk

K240664 is an FDA 510(k) clearance for the ALARA BMA Neuro Access Kit (ALARA BMAN and ALARA BMAC Kit). Classified as Instrument, Biopsy (product code KNW), Class II - Special Controls.

Submitted by SurGenTec, LLC (Boca Raton, US). The FDA issued a Cleared decision on August 9, 2024 after a review of 154 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 876.1075 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all SurGenTec, LLC devices

FDA 510(k) Submission Details - K240664

510(k) Number K240664 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 08, 2024
Decision Date August 09, 2024
Days to Decision 154 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d slower than avg
Panel avg: 115d · This submission: 154d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KNW Device Classification - Class 2, Special Controls

Product Code KNW Instrument, Biopsy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1075
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - KNW Instrument, Biopsy

All 289
Devices cleared under the same product code (KNW) and FDA review panel - the closest regulatory comparables to K240664.
Triopsy Actuator (TMSDGB)
K242228 · Triopsy Medical, Inc. · Jan 2025
Mammotome AutoCore™ Single Insertion Core Biopsy System
K243095 · Devicor Medical Products, Inc. · Oct 2024
TRAP EASY
K242029 · H.S Hospital Service S.P.A · Oct 2024
Automatic Biopsy Needle BAM, Semi-Automatic Needle BIM
K233294 · Itp Innovative Tomography Products GmbH · Jun 2024
M·Biopsy /SureCore Automatic Disposable Biopsy Needle, M·Biopsy /SureCore Semi-automatic Disposable Biopsy Needle, M·Biopsy /SureAim Coaxial Biopsy Needle
K233031 · Canyon Medical, Inc. · Jan 2024
SUREcore Prime Biopsy Instrument
K230646 · Uro-1 Medical, Inc. · Nov 2023